ADME (Absorption, Distribution, Metabolism And Elimination) Toxicology Testing Market By Product ( Instruments, Software Solutions, Assay Systems, Reagents & Others), Technology (In-vitro Tests, In-vivo Tests) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on ADME toxicology testing market studies various product and technology types. ADME is the abbreviation for absorption, distribution, metabolism and elimination, a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. ADME comprises set of four processes that develop the performance of a drug on human tissue and ADME toxicology testing is applied for the development of a new drug. The key factors assisting the growth of instruments and assay systems market are enhanced accuracy and predictability of ADME –Tox technology, market shift towards in-vitro assays for toxicological studies and increasing global adoption of novel ADME toxicology testing instruments and assay systems.

For the purpose of this study, the global ADME toxicology testing market on the basis of product type is segmented into instruments, software solutions, assays systems, reagents, and others. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

On the basis of technology type ADME toxicology testing market is segmented as in-vivo, and in-vitro; in-vitro technology is bifurcated as biochemical testing and cell testing. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

The ADME toxicology testing market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

The major key players profiled in the ADME toxicology testing market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Cellartis AB, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Caliper Life Sciences, Inc., Promega Corporation, Life Technologies Corporation, Cyprotex PLC, Beckman Coulter, Inc., Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., MultiCASE, Inc., Xceleron, Inc., ACEA Biosciences, Inc., Albany Molecular Research, Inc., and CeeTox, Inc.

Based on the type of technology, the ADME toxicology testing market is segmented into:

  • In-vitro Tests
    • Biochemical Testing
    • Cell Testing
  • In-vivo Tests

In base year 2015, the in-vivo tests accounted the largest share in the market in terms of revenue (USD) due to its efficiency in terms of cost and time over other toxicity testing techniques. With benefits such as increase throughput screening, the ADME toxicology prediction technology is expected to increase in the near future. In-vitro technologies are anticipated to project lucrative growth owing to increasing ethical concerns over animal use in clinical trials. Application of ADME toxicity computer modeling is expected to rise because of associated benefits related to increase throughput screening. The key factors driving ADME toxicology testing market are enhanced accuracy and predictability of ADME-Tox technology, rising ethical concerns over the use of animals in clinical trials, growing prominence of cell-based assays in drug discovery and ADME analysis, and rising demand and awareness for cardiotoxicity and cell imaging.

ADME Toxicology Testing  Market

For the purpose of this study, the global ADME toxicology testing market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

ADME Toxicology Testing Market

In base year 2015, North America accounted for the largest share in the global ADME toxicology testing market, followed by Asia-Pacific, Europe, LATAM and MEA. The key factors assisting the market growth in this region are the supportive government regulations towards new drug development. According to market experts, reduced number of drug failures due to the adoption of ADME toxicology testing is boosting the demand from pharmaceutical and biotechnology companies. Technological advancements such as the application of in-silico techniques that make use of computer-based testing methods to get fast results are expected to drive the ADME toxicology testing market in the future.The Asia-Pacific region (comprising Japan, China and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2016 - 2022. The key factors such as ongoing shift of research work to low cost countries, increased government support, and rising collaborations between foreign pharmaceutical companies and local research laboratories.

Choose License Type
Published Date:  May 2016
Category:  Pharmaceuticals
Report ID:   57834
Report Format:   PDF
Pages:   120
Rating:    4.1 (50)
Connect With Us
+1-408-641-3282
24/7 Research Support